Grown Rogue International (GRUSF) Minority Interest (2019 - 2026)
Grown Rogue International's (GRUSF) quarterly Minority Interest came in at $6.4 million in Q1 2026, up 344.33% year-on-year from $1.4 million in Q1 2025, and up 112.39% quarter-over-quarter from $3.0 million in Q4 2025.
Grown Rogue International (GRUSF) Minority Interest (2019 - 2026) Analysis & Trends
Grown Rogue International's Minority Interest history runs 8 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- On a quarterly basis, Minority Interest rose 344.33% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 344.33% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 84.98% from the prior year.
- Minority Interest climbed to $6.4 million in Q1 2026 per GRUSF's latest filing, from $3.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $1564.9 billion in Q3 2025 and bottomed at $735477.6 in Q3 2024.
- The 5-year median for Minority Interest is $1.5 million (2025), against an average of $111.8 billion.
- Across the five-year window, Minority Interest plunged 50.97% in 2023 and jumped 212778638.89% in 2025, its largest moves.
- Year by year, Minority Interest stood at $2.0 million in 2022, then sank by 62.9% to $744322.5 in 2023, then soared by 118.99% to $1.6 million in 2024, then surged by 84.98% to $3.0 million in 2025, then jumped by 112.39% to $6.4 million in 2026.
- Per Business Quant, the three latest GRUSF Minority Interest figures stand at $6.4 million (Q1 2026), $3.0 million (Q4 2025), and $1564.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.40 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 1,564.94 Bn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 735,477.62 |
| Jun 30, 2024 | 813,415.79 |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 744,322.48 |
| Oct 31, 2023 | 983,717.00 |
| Apr 30, 2023 | 772,721.00 |
| Jan 31, 2023 | 773,588.00 |
| Oct 31, 2022 | 2.01 Mn |
| Oct 31, 2021 | 2.03 Mn |
| Apr 30, 2021 | -43,793.00 |
| Jan 31, 2021 | 346,513.00 |
| Oct 31, 2020 | -33,383.00 |
| Jul 31, 2020 | 5,225.00 |
| Apr 30, 2020 | -17,611.00 |